Brilinta (Ticagrelor)

Brilinta (Ticagrelor) Product Description

Brilinta, with the active ingredient Ticagrelor, is a prescription medication used to reduce the risk of heart attack and stroke in patients with acute coronary syndrome or a history of heart problems. It belongs to a class of drugs known as antiplatelet agents, which work by preventing blood clots from forming.

How Brilinta Works

Brilinta inhibits platelet aggregation, thereby reducing the likelihood of clot formation. It does so by reversibly binding to the P2Y12 receptor on platelets, which is essential for platelet activation and aggregation.

Indications

Brilinta is indicated for:

• Patients experiencing a heart attack (myocardial infarction).
• Patients with unstable angina.
• Patients who have undergone angioplasty or stenting.

Dosage and Administration

The typical dosage for Brilinta is 90 mg taken twice daily, usually in combination with aspirin. It's important to follow your healthcare provider's instructions regarding dosage and duration of treatment.

Possible Side Effects

Common side effects of Brilinta may include:

• Bleeding or bruising more easily.
• Shortness of breath.
• Headache.
• Fatigue.

Seek immediate medical attention if you experience severe bleeding or signs of an allergic reaction.

Precautions

Before taking Brilinta, inform your doctor if you have:

• A history of bleeding disorders.
• Severe liver or kidney problems.
• Any upcoming surgeries or dental procedures.

Drug Interactions

Brilinta may interact with other medications. Inform your healthcare provider about all prescription and over-the-counter medications you are taking, especially:

• Other antiplatelet drugs.
• Blood thinners.
• Certain antidepressants.

Conclusion

Brilinta is a vital medication for patients at risk of cardiovascular events. Always consult with your healthcare provider for personalized medical advice and to ensure the safe use of this medication.